Icosapent Ethyl Capsule shortage
Icosapent Ethyl Capsule is currently listed in shortage by the FDA. The FDA lists 2 affected products. This page was last refreshed from FDA data on Sep 28, 2026.
Apotex is permanently stopping production of its icosapent ethyl 1 g capsules. Other makers — including Hikma, Teva, Northstar Rx, and Camber — still list icosapent ethyl capsules in both 500 mg and 1 g strengths as available.
Don’t stop or change your therapy on your own — talk with your prescriber about the plan that fits you, and ask your pharmacist what’s actually available (see options).
Do you take this drug? See the ‘What to do’ recommendation from Dr. Brian Staiger, PharmD →What’s in shortage — at a glance
These figures count only the manufacturers that reported this shortage to the FDA — not every company that makes Icosapent Ethyl Capsule. Other makers that haven’t reported a problem are shown in the green card below.
Shortage timeline
-
Apr 1, 2026Currently in shortage2 of 2 products affected.
-
Apr 1, 2026First reported to the FDA2 products first listed.
Built from FDA posting and update dates. The end date FDA publishes is the posting/update date, not a true resolution date, so durations are approximate.
What exactly is on backorder — by manufacturer
Manufacturer: Apotex Corp. 📞 800-706-5575 2 NDCS click to expand
| Status | NDC / product | Strength | Availability | Related information | Reason |
|---|---|---|---|---|---|
| To Be Discontinued | Icosapent Ethyl, Capsule, 1 g (NDC 60429-005-12) | — | — | Discontinuation of the manufacture of the drug | — |
| To Be Discontinued | Icosapent Ethyl, Capsule, 1 g (NDC 61474-9711-1) | — | — | Discontinuation of the manufacture of the drug | — |
These rows are manufacturer reports to the FDA for Icosapent Ethyl Capsule — they do not necessarily cover every manufacturer that makes this drug. A company appears here only if it told the FDA it has a supply problem, so other makers may still have stock. That’s the basis for the Where else can I get Icosapent Ethyl Capsule? options further down this page.
Why is Icosapent Ethyl Capsule in shortage?
So here's what's going on with this medication. Apotex Corp. has reported to the FDA that they are permanently stopping the manufacturing of their 1 g icosapent ethyl capsules. This affects two specific packages of theirs (NDC 61474-9711-1 and NDC 60429-005-12). Unfortunately, Apotex did not share a more specific public reason for why they made this decision — just that they are discontinuing production of this drug.
It's worth knowing that this report only reflects what Apotex Corp. has filed with the FDA. It does not mean icosapent ethyl is disappearing from the market entirely, as other manufacturers may still be producing it and are listed separately.
Based on the manufacturer-reported reason(s) and notes on file with the FDA for Icosapent Ethyl Capsule, summarized in plain English by HelloPharmacist. A drug can be short for more than one reason, and the FDA updates these as manufacturers report changes.
What should I do if I take Icosapent Ethyl Capsule?
Icosapent ethyl capsules are currently on the FDA shortage list, so I want to walk you through what this means for you.
The affected strength is the 1 g capsule, which is reported by Apotex Corp. as having no available source right now. The reason listed is that this manufacturer is discontinuing production of the drug — in other words, this particular company's supply problem may be permanent rather than a short-term gap.
Here is the reassuring part: this report reflects only one manufacturer. The same medicine, in the same 1 g capsule form, is still listed as being made by several other companies. That means your pharmacy may be able to source it elsewhere, even though it may not sit on their local shelf today.
What you can do:
- Do not stop, skip, or change your dose on your own.
- Ask your pharmacy to check wholesalers and other manufacturers for the 1 g capsule, since the same medicine is still made by other companies.
- If your pharmacy cannot find your exact capsule, talk with your prescriber or pharmacist about your options.
Manufacturer contact numbers are listed on this page for reference, though your pharmacy usually handles those calls. This is general national data and may not match your local pharmacy's actual stock.
- Don’t stop or change the medication on your own — talk to your prescriber first.
- If this is part of an ongoing or essential regimen (for example HIV treatment or prevention, seizure, heart, transplant, diabetes or mental-health medicines), do not skip or ration doses — contact your pharmacist or prescriber right away to arrange continued supply before you run out.
- Ask your pharmacy to check other manufacturers, strengths, package sizes, and nearby stores.
- Ask your prescriber whether a different strength, formulation, or the brand/generic version is appropriate.
Uses, dosing, side effects, prices, and the complete FDA label — written in plain English and pharmacist-reviewed.
Where else can I get Icosapent Ethyl Capsule?
FDA shortages are manufacturer-reported — a company only shows up on the shortage list if it told the FDA it has a supply problem, so not every maker of Icosapent Ethyl Capsule is necessarily short. Below we pull together the other still-marketed options that are not reported in shortage: the same medicine from manufacturers that haven’t reported a problem, and alternative dosage forms. These may still be out of stock at your pharmacy, and only your prescriber or pharmacist can decide what’s right for you.
Same medicine, other manufacturers (not reported short)
Same active ingredient, dosage form & route as the shortage (matched on the FDB HICL ingredient code), from makers that have not filed a shortage with the FDA:
| Product | Strength | Form / route | Manufacturer | NDC |
|---|---|---|---|---|
| Icosapent Ethyl | ICOSAPENT ETHYL 1 g/1 | Capsule · Oral | Hikma Pharmaceuticals USA Inc. | 00054-0508-23 |
| Icosapent Ethyl | ICOSAPENT ETHYL .5 g/1 | Capsule · Oral | Hikma Pharmaceuticals USA Inc. | 00054-0621-27 |
| Icosapent Ethyl | ICOSAPENT ETHYL 500 mg/1 | Capsule, Liquid Filled · Oral | Teva Pharmaceuticals, Inc. | 00480-0126-49 |
| Icosapent Ethyl | ICOSAPENT ETHYL 1 g/1 | Capsule, Liquid Filled · Oral | Teva Pharmaceuticals, Inc. | 00480-0127-89 |
| Icosapent Ethyl | ICOSAPENT ETHYL 1 g/1 | Capsule · Oral | Northstar Rx LLC | 16714-0636-01 |
| Icosapent Ethyl | ICOSAPENT ETHYL .5 g/1 | Capsule · Oral | Camber Pharmaceuticals, Inc. | 31722-0298-24 |
| Icosapent Ethyl | ICOSAPENT ETHYL 1 g/1 | Capsule · Oral | Camber Pharmaceuticals, Inc. | 31722-0299-12 |
| Icosapent Ethyl | ICOSAPENT ETHYL 1 g/1 | Capsule, Liquid Filled · Oral | AvKARE | 42291-0046-12 |
| Icosapent Ethyl | ICOSAPENT ETHYL 1 g/1 | Capsule, Liquid Filled · Oral | EPIC PHARMA, LLC | 42806-0560-12 |
| Icosapent | ICOSAPENT ETHYL 1000 mg/1 | Capsule · Oral | Dr. Reddy's Laboratories, Inc. | 43598-0267-04 |
| Icosapent Ethyl | ICOSAPENT ETHYL 500 mg/1 | Capsule · Oral | Dr. Reddy's Laboratories, Inc. | 43598-0746-72 |
| Vascepa | ICOSAPENT ETHYL 1000 mg/1 | Capsule · Oral | Amarin Pharma Inc. | 52937-0001-20 |
Therapeutic equivalents & pricing 30 productsclick to expand
Orange Book–rated equivalents of the affected strengths, with the latest NADAC price (a federal retail-acquisition benchmark, not your copay) and an evidence-based availability label. Cheapest first.
| Product | Manufacturer | Package | NADAC $/unit | AB rating | Availability |
|---|---|---|---|---|---|
| Icosapent Ethyl 1 g | Hikma | 120 capsules | $0.441 | AB | Availability likely |
| Icosapent Ethyl 1 g | Teva | 120 capsules | $0.441 | AB | Availability likely |
| Icosapent Ethyl 1 g | Northstar | 120 capsules | $0.441 | AB | Availability likely |
| Icosapent Ethyl 1 g | Camber | 120 capsules | $0.441 | AB | Availability likely |
| Icosapent Ethyl 1 g | EPIC | 120 capsules | $0.441 | AB | Availability likely |
| Icosapent 1000 mg | Dr. | 120 capsules | $0.441 | AB | Availability likely |
| Icosapent Ethyl 1 g | Apotex | 120 capsules | $0.441 | AB | Availability likely |
| Icosapent Ethyl 1 g | American | 30 capsules | $0.441 | AB | Availability likely |
| Icosapent ethyl 1 g | Amneal | 120 capsules | $0.441 | AB | Availability likely |
| Icosapent Ethyl 1 g | Vitruvias | 120 capsules | $0.441 | AB | Availability likely |
| icosapent ethyl 1 g | Zydus | 120 capsules | $0.441 | AB | Availability likely |
| Icosapent Ethyl 1 g | Northstar | 120 capsules | $0.441 | AB | Availability likely |
| Icosapent Ethyl 1 g/g | Torrent | 120 g | — | AB | FDA listed |
| icosapent ethyl 1 g | Softgel | 120 capsules | — | AB | FDA listed |
| Icosapent Ethyl 1 g | AvKARE | 120 capsules | — | AB | Discontinued |
| Icosapent Ethyl 1 g | EPIC | 120 capsules | — | AB | FDA listed |
| Vascepa 1000 mg | Amarin | 4 capsules | — | AB | Discontinued |
| Vascepa 1000 mg | Amarin | 120 capsules | — | AB | FDA listed |
| Vascepa 1000 mg | Amarin | 8 capsules | — | AB | FDA listed |
| Icosapent Ethyl 1 g | Golden | 120 capsules | — | AB | FDA listed |
| Vascepa 1000 mg | Bryant | 30 capsules | — | AB | FDA listed |
| Icosapent Ethyl 1 g | Bryant | 120 capsules | — | AB | FDA listed |
| Icosapent 1000 mg | Bryant | 120 capsules | — | AB | FDA listed |
| Icosapent Ethyl 1 g | Qilu | 120 capsules | — | AB | FDA listed |
| Icosapent Ethyl 1 g | Bryant | 120 capsules | — | AB | FDA listed |
| Icosapent Ethyl 1 g | Bryant | 30 capsules | — | AB | FDA listed |
| Icosapent Ethyl 1 g | Bryant | 30 capsules | — | AB | FDA listed |
| Icosapent Ethyl 1 g | Bryant | 30 capsules | — | AB | FDA listed |
| Icosapent Ethyl 1 g | Bryant | 120 capsules | — | AB | FDA listed |
| Icosapent Ethyl 1 g | XLCare | 120 capsules | — | AB | FDA listed |
Equivalents share the same ingredient, strength, dosage form and route; an AB rating means the FDA considers them substitutable. NADAC is a national retail-pharmacy acquisition benchmark from CMS — not what you pay. Availability is inferred from recent pricing, not a stock check.
Other drugs in the same treatment class
These are different medicines — not other versions of Icosapent Ethyl Capsule — that fall in the same broad treatment class (lipotropics) . They are not automatic substitutes: they can differ in how they work, dosing, effectiveness, side effects and what they’re approved to treat. Do not switch on your own. This list is for information only — ask your prescriber or pharmacist whether any of them is appropriate for you.
Identity & classification
Where does this data come from?
Other cardiovascular shortages
Icosapent Ethyl Capsule shortage FAQs
Is Icosapent Ethyl Capsule in shortage?
Which products are affected?
When will Icosapent Ethyl Capsule be available again?
Can I still get Icosapent Ethyl somewhere?
What should I do if I take Icosapent Ethyl Capsule?
Still have a question about the Icosapent Ethyl Capsule shortage?
Ask a pharmacist about this shortage →View Icosapent Ethyl Capsule on the FDA drug-shortage database →
Where does this data come from?
/drug/shortages) — drug, manufacturer & contact, NDC/product, status, availability, reason, therapeutic category and posting/update dates. Current / To Be Discontinued = active; Resolved is kept for history. The Supply-Risk rating is assessed per active ingredient and adds the FDA NDC Directory (still-marketed manufacturers by ingredient & form); same-medicine and equivalent products use First Databank classification + CMS NADAC pricing; Medicaid use + most-affected states come from CMS Medicaid State Drug Utilization Data. Reference only — confirm current status with the manufacturer or FDA before acting on it.